Loading stock data…
Zoetis Inc. (ZTS)
$73.25-2.84 (-3.73%)
Market ClosedLast close Jun 29
Zoetis Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Zoetis Inc. in the Healthcare sector is trading at $73.25 with a market capitalization of $32.6B. Wall Street consensus targets $124.00 (17 analysts), implying a +69.3% move over the next 12 months. The stock is currently near its 52-week low of $72.38, remaining 37.8% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +69.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.26B↓ | $2.39B↓ | $2.40B↓ | $2.46B↑ | $2.20B |
| Gross Profit | $1.62B↓ | $1.68B↓ | $1.72B↓ | $1.81B↑ | $1.58B |
| Operating Income | $822.00M↓ | $826.00M↓ | $936.00M↓ | $989.00M↑ | $812.00M |
| Net Income | $601.00M↓ | $603.00M↓ | $721.00M↑ | $718.00M↑ | $602.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the Uni...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$32.57B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
12.74
Beta
Defensive asset. Lower volatility than the S&P 500.
0.86
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.81%
ROE
Elite ROE. Management converts capital into profit efficiently.
81.75%
Volume
Today's trading volume
6.52M
Recent News
Is Zoetis Inc. (ZTS) A Good Stock To Buy Now?
Is ZTS a good stock to buy? We came across a bullish thesis on Zoetis Inc. on r/ValueInvesting by ringdingjinglejangle. In this article, we will summarize the bulls’ thesis on ZTS. Zoetis Inc.’s share was trading at $75.89 as of June 22nd. ZTS’s trailing and forward P/E were 12.44 and 11.10 respectively according to Yahoo Finance. Zoetis […]
U.S., Mexico open sterile fly facility to combat screwworm outbreak
Investing.com -- The United States and Mexico have opened a new facility in southern Mexico to produce sterile flies aimed at stopping the spread of the New World screwworm, Bloomberg reported on Saturday, as the livestock pest continues to threaten cattle herds across North America.
Zoetis (ZTS) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Zoetis (ZTS) closed at $76.09, marking a -2.22% move from the previous day.
Strength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength?
4D Molecular Therapeutics (FDMT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
2 Reasons to Like ZTS and 1 to Stay Skeptical
Zoetis has gotten torched over the last six months - since December 2025, its stock price has dropped 36.6% to $78.46 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.